CHEN; DUNG-TSA

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHEN; DUNG-TSA.The latest application filed is for "theranostic tools for management of pancreatic cancer and its precursors".

Company Profile

3.10.12

CHEN; DUNG-TSA - TAMPA FL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Theranostic Tools For Management Of Pancreatic Cancer And Its Precursors App 20200063215 - PERMUTH; JENNIFER ; et al.	2020-02-27
Microrna Assay For Detection And Management Of Pancreatic Cancer Precursors App 20190376143 - MALAFA; MOKENGE P. ; et al.	2019-12-12
MicroRNA assay for detection and management of pancreatic cancer precursors Grant 10,240,208 - Malafa , et al.	2019-03-26
Biomarkers and methods for predicting benefit of adjuvant chemotherapy Grant 10,240,206 - Cress , et al.	2019-03-26
Microrna Assay For Detection And Management Of Pancreatic Cancer Precursors App 20170022571 - MALAFA; MOKENGE P. ; et al.	2017-01-26
Bad phosphorylation determines ovarian cancer chemo-sensitivity and patient survival Grant 9,528,982 - Lancaster , et al. December 27, 2	2016-12-27
Biomarkers And Methods For Predicting Benefit Of Adjuvant Chemotherapy App 20150376713 - Cress; Douglas W. ; et al.	2015-12-31
Malignancy-risk signature from histologically normal breast tissue Grant 9,195,796 - Chen , et al. November 24, 2	2015-11-24
Gene signature for the prediction of NF-kappaB activity Grant 9,115,388 - Beg , et al. August 25, 2	2015-08-25
Cancer platinum resistance detection and sensitization method Grant 9,063,143 - Lancaster , et al. June 23, 2	2015-06-23
Gene Signature for the Prediction of NF-kappaB Activity App 20140302060 - Beg; Amer A. ; et al.	2014-10-09
Methods of predicting high grade gliomas using senescence associated genes Grant 8,741,575 - Coppola , et al. June 3, 2	2014-06-03
Bad Phosphorylation Determines Ovarian Cancer Chemo-sensitivity And Patient Survival App 20140017703 - Lancaster; Johnathan ; et al.	2014-01-16
Method Of Diagnosing Early Stage Non-small Cell Lung Cancer App 20130252831 - Chen; Dung-Tsa	2013-09-26
Bad Pathway Gene Signature App 20130011393 - Lancaster; Johnathan Mark ; et al.	2013-01-10
Methods Of Predicting High Grade Gliomas Using Senescence Associated Genes App 20120322687 - Coppola; Domenico ; et al.	2012-12-20
Cancer Platinum Resistance Detection And Sensitization Method App 20110166095 - Lancaster; Johnathan M. ; et al.	2011-07-07
Seven Gene Breast Cancer Predictor App 20110046002 - Yeatman; Timothy ; et al.	2011-02-24
Malignancy-risk Signature From Histologically Normal Breast Tissue App 20110039723 - Chen; Dung-Tsa ; et al.	2011-02-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.